ophthalmology

Ophthalmic Drugs 2018

https://pharmaphorum.com/events/ophthalmic-drugs-2018/

Priority review voucher prices fall again after Spark’s $110m sale

https://pharmaphorum.com/news/spark-sells-priority-review-voucher-to-jazz/

Novartis app could revolutionise ophthalmic clinical trials

https://pharmaphorum.com/news/novartis-app-could-revolutionise-ophthalmic-clinical-trials/

NICE rejects rare eye disease therapy

https://pharmaphorum.com/news/nice-rejects-rare-eye-disease-therapy/

Digital health round-up: Could Nokia kill off digital health unit?

https://pharmaphorum.com/views-and-analysis/digital-health-round-nokia-kill-off-digital-health-unit/

AI predicts heart attack risk factors from retinal scans

https://pharmaphorum.com/news/ai-can-used-predict-heart-attack-risk-factors/

FDA makes history, approving Spark’s eye gene therapy

https://pharmaphorum.com/news/luxturna-spark-therapeutics/

Regeneron/Bayer axe eye combination drug

https://pharmaphorum.com/news/regeneronbayer-axe-eye-combination-drug/

Europe’s Leading Ophthalmic Conference is Just 1 week away

https://pharmaphorum.com/partner-content/europes-leading-ophthalmic-conference-just-1-week-away/

«< 4 5 6 7 8 >»

Close in 10 seconds

Pharmaphorum.com

Search